+Compare
LLY
Stock ticker:
NYSE
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
404.19B

LLY Price Prediction, Eli Lilly & Co AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar

GET INTRADAY SIGNALS
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EDT May 26, 2023

Aroon Indicator for LLY shows an upward move is likely

LLY's Aroon Indicator triggered a bullish signal on May 26, 2023. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 352 similar instances where the Aroon Indicator showed a similar pattern. In of the 352 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LLY advanced for three days, in of 361 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for LLY moved out of overbought territory on May 22, 2023. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on May 23, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on LLY as a result. In of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for LLY turned negative on May 18, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LLY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

LLY broke above its upper Bollinger Band on May 03, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 59, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. LLY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: LLY's P/B Ratio (36.101) is very high in comparison to the industry average of (6.199). LLY has a moderately high P/E Ratio (67.568) as compared to the industry average of (30.267). Projected Growth (PEG Ratio) (1.649) is also within normal values, averaging (3.530). LLY has a moderately low Dividend Yield (0.010) as compared to the industry average of (0.027). LLY's P/S Ratio (13.889) is very high in comparison to the industry average of (4.057).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

A.I. Advisor
published Earnings

LLY is expected to report earnings to rise 23.46% to $2.00 per share on August 08

Eli Lilly & Co LLY Stock Earnings Reports
Q2'23
Est.
$2.00
Q1'23
Missed
by $0.07
Q4'22
Beat
by $0.29
Q3'22
Beat
by $0.07
Q2'22
Missed
by $0.45
The last earnings report on April 27 showed earnings per share of $1.62, missing the estimate of $1.69. With 2.21M shares outstanding, the current market capitalization sits at 404.19B.
A.I.Advisor
published Dividends

LLY is expected to pay dividends on June 09, 2023

Eli Lilly & Co LLY Stock Dividends
A dividend of $1.13 per share will be paid with a record date of June 09, 2023, and an ex-dividend date of May 12, 2023. The last dividend of $1.13 was paid on March 10. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Biogen (NASDAQ:BIIB).

Industry description

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

Market Cap

The average market capitalization across the Pharmaceuticals: Major Industry is 80.25B. The market cap for tickers in the group ranges from 72.83K to 404.19B. LLY holds the highest valuation in this group at 404.19B. The lowest valued company is CRXTQ at 72.83K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Major Industry was -2%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was 2%. SNPHF experienced the highest price growth at 7%, while SCLX experienced the biggest fall at -12%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Major Industry was -11%. For the same stocks of the Industry, the average monthly volume growth was -5% and the average quarterly volume growth was 125%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 28
P/E Growth Rating: 56
Price Growth Rating: 53
SMR Rating: 52
Profit Risk Rating: 59
Seasonality Score: 18 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Lilly Corporate Center
Phone
+1 317 276-2000
Employees
39000
Web
https://www.lilly.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRTH3.370.11
+3.37%
Priority Technology Holdings
SNOW150.012.10
+1.42%
Snowflake
NTST17.640.08
+0.46%
NetSTREIT Corp
XPL0.59N/A
N/A
Solitario Zinc Corp
IPAR128.39-1.32
-1.02%
Inter Parfums

LLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LLY has been loosely correlated with MRK. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if LLY jumps, then MRK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LLY
1D Price
Change %
LLY100%
-0.36%
MRK - LLY
56%
Loosely correlated
-1.10%
JNJ - LLY
54%
Loosely correlated
-0.04%
BIIB - LLY
49%
Loosely correlated
+0.51%
BMY - LLY
47%
Loosely correlated
-1.15%
AMGN - LLY
46%
Loosely correlated
-0.24%
More